Premium
Homozygous variants in pyrroline‐5‐carboxylate reductase 2 ( PYCR2 ) in patients with progressive microcephaly and hypomyelinating leukodystrophy
Author(s) -
Meng Linyan,
Donti Taraka,
Xia Fan,
Niu Zhiyv,
Al Shamsi Aisha,
Hertecant Jozef,
AlJasmi Fatma,
Gibson James B.,
Nagakura Honey,
Zhang Jing,
He Weimin,
Eng Christine,
Yang Yaping,
Elsea Sarah H.
Publication year - 2017
Publication title -
american journal of medical genetics part a
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.064
H-Index - 112
eISSN - 1552-4833
pISSN - 1552-4825
DOI - 10.1002/ajmg.a.38049
Subject(s) - compound heterozygosity , exome sequencing , microcephaly , leukodystrophy , galactosemia , biology , missense mutation , genetics , proband , psychomotor retardation , medicine , disease , pathology , phenotype , biochemistry , gene , mutation , galactose , alternative medicine
Pyrroline‐5‐carboxylate reductase 2, encoded by PYCR2 , is one of the three homologous enzymes that catalyze the last step of proline synthesis. Homozygous variants in PYCR2 have been reported in patients from multiple consanguineous families with hypomyelinating leukodystrophy 10 (HLD10) (MIM: 616420). Here, we report five additional patients from three families with homozygous nonsense or missense variants in PYCR2 , identified through clinical exome sequencing. All patients presented with postnatally acquired microcephaly, moderate to profound global developmental delay, and failure to thrive. Brain MRI in these patients showed thin corpus callosum, delayed myelination, and generalized white‐matter volume loss. Additional phenotypes that were less consistent among patients included seizures or seizure‐like movements, spasticity and ataxic gait, recurrent vomiting, cortical blindness, dysmorphic features, joint contractures, and irritability. Exome sequencing identified homozygous variants in PYCR2 in the proband from each family: c.28C>T (p.(Glu10Ter)), c.796C>T (p.(Arg266Ter)), and c.577G>A (p.(Val193Met)). Subsequent targeted analyses demonstrated co‐segregation of the disease with the variant in the family. Despite the metabolic role of PYCR2, routine serum metabolic test in these patients were normal. To further understand the disease etiology and functions of PYCR2, small molecule metabolomics profiling was performed in plasma from three severely affected patients. No significant changes were identified in proline biosynthesis pathway or related metabolites. Studying the clinical features and the metabolic profiles of the PYCR2‐deficient patients provides a more comprehensive picture for this newly identified disorder and facilitates further research on the gene function and disease etiology. © 2016 Wiley Periodicals, Inc.